Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS

Travel Medicine and Infectious Disease

Volumn 5, Issue 6, 2007, Pages 380-384

  Lopez Gigosos R ^a   Garcia Fortea P ^a   Reina Dona E ^a   Plaza Martin E ^a  

^a International Vaccination Centre   (Spain)

Author keywords

Cholera; Enterotoxigenic Escherichia coli (ETEC); Oral cholera vaccine; Travellers' diarrhoea; Vaccine efficacy

Indexed keywords

CHOLERA VACCINE; ESCHERICHIA COLI ENTEROTOXIN;

ABSENCE OF SIDE EFFECTS; ADULT; AFRICA; AGE; ARTICLE; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CONTROLLED STUDY; FEMALE; GEOGRAPHY; HUMAN; INCIDENCE; INDIA; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTHEAST ASIA; SPAIN; TELEPHONE; TRAVEL; TRAVELLER DIARRHEA; VACCINATION;

ADMINISTRATION, ORAL; ADULT; AFRICA, CENTRAL; CHOLERA; CHOLERA VACCINES; COHORT STUDIES; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TRAVEL; VIBRIO CHOLERAE;

EID: 35548989671     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2007.06.001     Document Type: Article

References (12)

1. Freedman D.O., Weld L.H., Kozarsky P.E., et al. Spectrum of disease and relation to place exposure among ill returned travelers. N Engl J Med 354 (2006) 119-130
2. Connor BA. Prevention of specific infectious diseases: travellers' diarrhoea. In: Arguin PA, Kozarsky PE, Navin AW, editors. Travelers' health: yellow book. Health information for international travel 2005-2006. Atlanta: US Department of Health and Human Services, Public Health Service, CDC, 2005.
3. Ivanoff B. Travellers' diarrhea: which vaccines?. Bull Soc Pathol Exot 91 (1998) 456-460 [In French]
4. Hill D.R., Ford L., and Lalloo D.G. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis 6 (2006) 361-373
5. Steffen R., Castelli F., Dieter Nothdurft H., et al. Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea. J Travel Med 12 (2005) 102-107
6. Black R.E. Epidemiology of diarrhoeal disease: implications for control by vaccines. Vaccine 11 (1993) 100-106
7. De Juanes JR, Per-Arne Parment Arrazola, P. Nueva vacuna frente al cólera y la diarrea del viajero. Vacunas 2006; 1: 33-7.
8. Landry P. Diarrhea and vaccines: current developments. Rev Med Suisse 2006; 2: 1240-2, 1244 [In French].
9. Svennerholm A.M., and Steele D. Microbial-gut interactions in health and disease. Progress in enteric vaccine development. Best Pract Res Clin Gastroenterol 18 (2004) 421-445
10. Clemens J.D., Sack D.A., Harris J.R., et al. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 158 (1988) 372-377
11. Clemens J.D., Stanton B.F., Harris J.R., et al. Exclusion of clinically atypical or microbiologically mixed diarrhoeal episodes from outcome events in a field trial of oral cholera vaccines. Int J Epidemiol 18 (1989) 440-445
12. Peltola H., Siitonen A., Kyronseppa H., et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338 (1991) 1285-1289